Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
26-28 August, 2025
APGA Annual ConferenceAPGA Annual Conference
Not Confirmed
Not Confirmed
20-23 July, 2025
Not Confirmed
Not Confirmed
24-25 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
APGA Annual ConferenceAPGA Annual Conference
Industry Trade Show
Not Confirmed
20-23 July, 2025
Industry Trade Show
Not Confirmed
24-25 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
28 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/28/3089475/0/en/Flare-Therapeutics-to-Participate-in-Jefferies-Global-Healthcare-Conference.html
14 Nov 2024
// BUSINESSWIRE
12 Nov 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/flare-therapeutics-announces-strategic-discovery-collaboration-with-roche-to-address-previously-undrugged-transcription-factor-targets-in-oncology-302301901.html
23 Apr 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/flare-therapeutics-appoints-douglas-manion-md-frcp-c-as-chief-executive-officer-302124574.html
10 Apr 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/flare-therapeutics-presents-data-at-aacr-2024-annual-meeting-characterizing-pparg-derived-immune-cell-patterns-in-urothelial-cancer-patients-after-anti-pd1-therapy-302112197.html
26 Jan 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/flare-therapeutics-presents-fx-909-phase-1-dose-escalation-and-expansion-clinical-trial-design-at-the-2024-asco-genitourinary-cancers-symposium-302045411.html
ABOUT THIS PAGE